雲頂新耀艾曲莫德亞洲多中心Ⅲ期臨床ENLIGHT UC研究(ES101002)結果榮登柳葉刀子刊 展示在亞洲患者中的突破性療效與安全性 Everest Medicines Limited Oct 09, 2025 18:24 HKT/SGT Read More
Everest Medicines Announces Publication of Etrasimod's Asian Multicenter Phase III ENLIGHT UC study (ES101002) Results in The Lancet Gastroenterology & Hepatology Everest Medicines Limited Oct 09, 2025 18:24 HKT/SGT Read More
Eisai and Biogen Announce U.S. Availability of LEQEMBI(R) IQLIK(TM) (lecanemab-irmb) Subcutaneous Injection Maintenance Dose for Treatment of Early Alzheimer's Disease Eisai Oct 08, 2025 11:03 HKT/SGT Read More
Olympus Launches SecureFlex, a Single-use Fine Needle Biopsy Device Olympus Oct 06, 2025 14:00 HKT/SGT Read More
Eisai Highlights Breadth of Oncology Research at ESMO 2025 Eisai Oct 03, 2025 17:01 HKT/SGT Read More
DOCOMO and PaMeLa Develop World's First Technology to Share Pain Perception Tailored to Individual Sensitivity NTT DOCOMO Oct 01, 2025 21:18 HKT/SGT Read More
The Second Proton Therapy System Begins Treatment at University of Tsukuba Hospital Hitachi, Ltd. Oct 01, 2025 19:37 HKT/SGT Read More
Olympus Commits to Advancing Sustainable Packaging Enabled by DuPont(TM) Tyvek(R) with Renewable Attribution Olympus Sep 30, 2025 12:00 HKT/SGT Read More
Bamboos Announces 2025 Annual Results Bamboos Health Care Holdings Limited Sep 29, 2025 18:01 HKT/SGT Read More
百本公布2025全年业绩 积极推进"科技+创新"与医疗健康的融合 Bamboos Health Care Holdings Limited Sep 29, 2025 17:51 HKT/SGT Read More
百本公佈2025全年業績 積極推進「科技+創新」與醫療健康的融合 Bamboos Health Care Holdings Limited Sep 29, 2025 17:39 HKT/SGT Read More
Hua Medicine Announces the Pharmaceutical Service of Hong Kong Department of Health of China has Officially Accepted the Application for Marketing Authorization of the New Drug Dorzagliatin Hua Medicine Sep 29, 2025 11:22 HKT/SGT Read More
"LEQEMBI(R)" (lecanemab) IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease Approved in China Eisai Sep 29, 2025 09:33 HKT/SGT Read More
China Medical System (867.HK; 8A8.SG) Positive Results from China Phase 3 Clinical Trial of Innovative Drug Ruxolitinib Cream with AD Indication China Medical System Holdings Limited Sep 28, 2025 16:00 JST Read More
China Medical System (867.HK; 8A8.SG) Positive Results from China Phase 3 Clinical Trial of Innovative Drug Ruxolitinib Cream with AD Indication China Medical System Holdings Limited Sep 28, 2025 15:00 HKT/SGT Read More
康哲藥業(867.HK;8A8.SG)創新藥磷酸蘆可替尼乳膏AD中國三期臨床取得積極結果 China Medical System Holdings Limited Sep 28, 2025 11:33 HKT/SGT Read More